135 related articles for article (PubMed ID: 15061359)
1. Diagnostic use of cerebral and extracerebral oxysterols.
Leoni V; Masterman T; Mousavi FS; Wretlind B; Wahlund LO; Diczfalusy U; Hillert J; Björkhem I
Clin Chem Lab Med; 2004 Feb; 42(2):186-91. PubMed ID: 15061359
[TBL] [Abstract][Full Text] [Related]
2. Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Novakova L; Axelsson M; Malmeström C; Zetterberg H; Björkhem I; Karrenbauer VD; Lycke J
J Neurol Sci; 2015 Nov; 358(1-2):201-6. PubMed ID: 26342940
[TBL] [Abstract][Full Text] [Related]
3. Oxysterols as biomarkers in neurodegenerative diseases.
Leoni V; Caccia C
Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid.
Leoni V; Caccia C
Biochem Pharmacol; 2013 Jul; 86(1):26-36. PubMed ID: 23541982
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
[TBL] [Abstract][Full Text] [Related]
6. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Björkhem I; Lövgren-Sandblom A; Leoni V; Meaney S; Brodin L; Salveson L; Winge K; Pålhagen S; Svenningsson P
Neurosci Lett; 2013 Oct; 555():102-5. PubMed ID: 24035896
[TBL] [Abstract][Full Text] [Related]
7. 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome.
Björkhem I; Patra K; Boxer AL; Svenningsson P
Front Neurol; 2018; 9():756. PubMed ID: 30245667
[TBL] [Abstract][Full Text] [Related]
8. Sulphatation does not appear to be a protective mechanism to prevent oxysterol accumulation in humans and mice.
Acimovic J; Lövgren-Sandblom A; Olin M; Ali Z; Heverin M; Schüle R; Schöls L; Fischler B; Fickert P; Trauner M; Björkhem I
PLoS One; 2013; 8(7):e68031. PubMed ID: 23844150
[TBL] [Abstract][Full Text] [Related]
9. On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review).
Björkhem I; Leoni V; Svenningsson P
J Steroid Biochem Mol Biol; 2019 Apr; 188():86-89. PubMed ID: 30586624
[TBL] [Abstract][Full Text] [Related]
10. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
van de Kraats C; Killestein J; Popescu V; Rijkers E; Vrenken H; Lütjohann D; Barkhof F; Polman CH; Teunissen CE
Mult Scler; 2014 Apr; 20(4):412-7. PubMed ID: 23959711
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease.
Tripodi D; Vitarelli F; Spiti S; Leoni V
Adv Exp Med Biol; 2024; 1440():337-351. PubMed ID: 38036888
[TBL] [Abstract][Full Text] [Related]
12. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.
Leoni V; Caccia C
Biochimie; 2013 Mar; 95(3):595-612. PubMed ID: 23041502
[TBL] [Abstract][Full Text] [Related]
13. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?
Leoni V; Shafaati M; Salomon A; Kivipelto M; Björkhem I; Wahlund LO
Neurosci Lett; 2006 Apr 10-17; 397(1-2):83-7. PubMed ID: 16406316
[TBL] [Abstract][Full Text] [Related]
14. Brain-Specific Oxysterols and Risk of Schizophrenia in Clinical High-Risk Subjects and Patients With Schizophrenia.
Sun Z; Zhao L; Bo Q; Mao Z; He Y; Jiang T; Li Y; Wang C; Li R
Front Psychiatry; 2021; 12():711734. PubMed ID: 34408685
[TBL] [Abstract][Full Text] [Related]
15. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
16. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers.
Leoni V; Masterman T; Patel P; Meaney S; Diczfalusy U; Björkhem I
J Lipid Res; 2003 Apr; 44(4):793-9. PubMed ID: 12562838
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of the association between maternal mid-pregnancy cholesterol and oxysterol concentrations and labor duration.
Rideout TC; Wallace J; Wen X; Barnabei VM; Kong KL; Browne RW
Lipids Health Dis; 2023 Mar; 22(1):37. PubMed ID: 36906556
[TBL] [Abstract][Full Text] [Related]
18. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
Holdenrieder S; Lütjohann D; Geiger S; von Bergmann K; Stieber P; Hamann GF
Neurosci Lett; 2004 Sep; 368(2):201-4. PubMed ID: 15351449
[TBL] [Abstract][Full Text] [Related]
19. Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers.
Boglione L; Caccia C; Civra A; Cusato J; D'Avolio A; Biasi F; Lembo D; Di Perri G; Poli G; Leoni V
J Steroid Biochem Mol Biol; 2021 Jun; 210():105854. PubMed ID: 33631373
[TBL] [Abstract][Full Text] [Related]
20. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
Leoni V; Mariotti C; Tabrizi SJ; Valenza M; Wild EJ; Henley SM; Hobbs NZ; Mandelli ML; Grisoli M; Björkhem I; Cattaneo E; Di Donato S
Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
